Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella
The development, clinical advancement and licensure of vaccines, and monitoring of vaccine effectiveness could be expedited and simplified by the ability to measure immunological endpoints that can predict a favorable clinical outcome.Antigen-specific and functional antibodies have been described in the context of naturally acquired immunity and va